Evidence map›Paper›PMID 35410286›Full record

ArticleAlzheimer's research & therapy2022

Reconfigured metabolism brain network in asymptomatic microtubule-associated protein tau mutation carriers: a graph theoretical analysis.

Li Liu, Min Chu, Binbin Nie, Lin Liu, Kexin Xie, Yue Cui, Yu Kong, Zhongyun Chen, Haitian Nan, Kewei Chen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's research & therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Li LiuDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Beijing, China.
Min ChuDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Beijing, China.
Binbin NieBeijing Engineering Research Center of Radiographic Techniques and Equipment, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.
Lin LiuDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Beijing, China.
Kexin XieDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Beijing, China.
Yue CuiDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Beijing, China.
Yu KongDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Beijing, China.
Zhongyun ChenDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Beijing, China.
Haitian NanDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Beijing, China.
Kewei ChenBanner Alzheimer's Institute, University of Arizona, School of Mathematics and Statistics, Arizona Alzheimer's Consortium, Arizona State University, Tempe, USA.
Pedro Rosa-NetoMcGill Centre for Studies in Aging, Alzheimer's Disease Research Unit, Montreal, H4H 1R3, Canada.
Liyong WuDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Beijing, China. wmywly@hotmail.com.
Capital Medical University · CNInstitute of High Energy Physics · CNMcGill University Health Centre · CANational Clinical Research Center for Digestive Diseases · CNSecond Hospital of Shanxi Medical University · CNShenyang Fifth People Hospital · CNUniversity of Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies exploring topological properties of the metabolic network during the presymptomatic stage of genetic frontotemporal dementia (FTD) are scarce. However, such knowledge is important for understanding brain function and disease pathogenesis. Therefore, we aimed to explore FTD-specific patterns of metabolism topology reconfiguration in microtubule-associated protein tau (MAPT) mutation carriers before the onset of symptoms.

methodsSix asymptomatic carriers of the MAPT P301L mutation were compared with 12 non-carriers who all belonged to the same family of FTD. For comparison, we included 32 behavioral variant FTD (bvFTD) patients and 33 unrelated healthy controls. Each participant underwent neuropsychological assessments, genetic testing, and a hybrid positron emission tomography (PET)/magnetic resonance imaging (MRI) scan. Voxel-wise gray matter volumes and standardized uptake value ratios were calculated and compared for structural MRI and fluorodeoxyglucose (FDG)-PET, separately. The sparse inverse covariance estimation method (SICE) was applied to topological properties and metabolic connectomes of brain functional networks derived from

resultsThe asymptomatic MAPT carriers performed normal global parameters of the metabolism network, whereas bvFTD patients did not. However, we revealed lost hubs in the ventromedial prefrontal, orbitofrontal, and anterior cingulate cortices and reconfigured hubs in the anterior insula, precuneus, and posterior cingulate cortex in asymptomatic carriers compared with non-carriers, which overlapped with the comparisons between bvFTD patients and controls. Similarly, significant differences in local parameters of these nodes were present between asymptomatic carriers and non-carriers. The reduction in the connectivity of lost hub regions and the enhancement of connectivity between reconfigured hubs and components of the frontal cortex were marked during the asymptomatic stage. Metabolic connectivity within the SN and DMN was enhanced in asymptomatic carriers compared with non-mutation carriers but reduced in bvFTD patients relative to controls.

conclusionsOur findings showed that metabolism topology reconfiguration, characterized by the earliest involvement of medial prefrontal areas and active compensation in task-related regions, was present in the presymptomatic phase of genetic FTD with MAPT mutation, which may be used as an imaging biomarker of increased risk of FTD.

Indexed as

Frontotemporal DementiaBrainFluorodeoxyglucose F18HumansMagnetic Resonance ImagingMutationFluorodeoxyglucose F18Brain networkFDG-PETFrontotemporal dementiaGraph theoryMAPT gene

Identifiers

PMID35410286
PMCPMC8996677
OpenAlexW4223495646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.